TradingView
CourtroomInvestments
Feb 18, 2024 7:06 AM

IPCALAB Long

IPCA LABORATORIESNSE

Description


  • In our previous update in July 2023, we mentioned that stock’s corrective phase could be over, and it is a Value Buy.
  • In October 2023, the stock cleared its potential resistance level around 900 along with MACD crossing above Trigger line.
  • This confirmed continuation of long term up-move.
  • Price is now initially expected to test 2535, with optimistic targets extending to 3700 and 5555.
More